Cancer statistics, 2009

Cited by (1,040)

Items 201–300 of 1,040

1. Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
   Xingxiang Pu, Guoliang Huang, Hongqiang Guo, Chengcheng Guo, Haoran Li, Ye Shen, Shengying Ling, Li Jiang, Ying Tian, Tong‐yu Lin · 2010 · Journal of Gastroenterology and Hepatology
2. Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
   Ignacio Romero, Robert C. Bast · 2012 · Endocrinology
3. High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
   Jiang, Tao, Chen, Ning, Zhao, Fei, Wang, Xiao-Jun, Kong, Beihua, Zheng, Wenxin, Zhang, Donna D. · 2010 · Cancer Research
4. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer
   Abel Sánchez‐Palencia, Mercedes Gómez‐Morales, José Antonio Gómez‐Capilla, V Pedraza, Laura Boyero, Rafael Rosell, María Esther Fárez‐Vidal · 2010 · International Journal of Cancer
5. Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians
   Amir Qaseem, Michael J. Barry, Thomas D. Denberg, Douglas K Owens, Paul Shekelle · 2013 · Annals of Internal Medicine
6. Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
   Allen S. Ho, Xin Huang, Hongbin Cao, Claudia Christman-Skieller, Kevin L. Bennewith, Quynh‐Thu Le, Albert C. Koong · 2010 · Translational Oncology
7. Factors associated with Type I and Type II endometrial cancer
   Ashley Sinclair Felix, Joel L. Weissfeld, Roslyn A. Stone, Robert P. Bowser, Mamatha Chivukula, Robert P. Edwards, Faina Y. Linkov · 2010 · Cancer Causes & Control
8. Characteristics of Missed or Interval Colorectal Cancer and Patient Survival: A Population-Based Study
   Niloy Jewel Samadder, Karen Curtin, Thérèse M.F. Tuohy, Lisa M. Pappas, Kenneth M. Boucher, Dawn Provenzale, Kerry G. Rowe, Geraldine P. Mineau, Ken Robert Smith, Richard Pimentel et al. · 2014 · Gastroenterology
9. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis
   Lukejohn W. Day, Annette Kwon, John M. Inadomi, Louise Christie Walter, Ma Somsouk · 2011 · Gastrointestinal Endoscopy
10. Colon cancer associated transcript‐1: A novel RNA expressed in malignant and pre‐malignant human tissues
    Aviram Nissan, Alexander Stojadinovic, Stella Mitrani‐Rosenbaum, David Halle, Ronit Grinbaum, Marina Roistacher, Andrea E. Bochem, Barış Emre Dayanç, Gerd Ritter, İsmail Gömceli et al. · 2011 · International Journal of Cancer
11. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1
    Ching-Wen Lin, Yih‐Leong Chang, Yu-Chiuan Chang, Jau-Chen Lin, Chun Chi Chen, Szu‐Hua Pan, Chen‐Tu Wu, Hsuan-Yu Chen, Shuenn Chen Yang, Tse-Ming Hong et al. · 2013 · Nature Communications
12. Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease
    Sokratis Trellakis, Kirsten Bruderek, Claudia Alexandra Dumitru, Hossein Gholaman, Xiang Gu, Ágnes Bánkfalvi, André Scherag, Jan Hütte, Nina Dominas, Götz Lehnerdt et al. · 2010 · International Journal of Cancer
13. miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer
    Kristen M. Foss, Chao Sima A, Donatella Ugolini, Monica Neri, Kristi E. Allen, Glen J. Weiss · 2011 · Journal of Thoracic Oncology
14. Importance of Age of Onset in Pancreatic Cancer Kindreds
    Brune, K. A., Lau, B., Palmisano, E., Canto, M., Goggins, M. G., Hruban, R. H., Klein, A. P. · 2010 · JNCI Journal of the National Cancer Institute
15. Modeling High-Grade Serous Ovarian Carcinogenesis from the Fallopian Tube
    Karst, Alison M., Levanon, Keren, Drapkin, Ronny · 2011 · Proceedings of the National Academy of Sciences
16. Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor
    Atul Bhanudas Shinagare, Nikhil H. Ramaiya, Jyothi Priya Jagannathan, Fiona M. Fennessy, Mary‐Ellen Taplin, Annick D. Van den Abbeele · 2010 · American Journal of Roentgenology
17. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.
    R. Y. Hsu, C. Chan, J. Spicer, M. Rousseau, B. Giannias, S. Rousseau, L. Ferri · 2011 · Cancer Research
18. The Confluence of Sex Hormones and Aging on Immunity
    Gubbels Bupp, Melanie R., Potluri, Tanvi, Fink, Ashley L., Klein, Sabra L. · 2018 · Frontiers in Immunology
19. Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
    Anirban Kumar Mitra, Kenjiro Sawada, Payal Tiwari, kit Mui, K Gwin, Ernst R. Lengyel · 2010 · Oncogene
20. Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
    Hongjiang Wang, Guang Tan, Lei Dong, Lei Cheng, Kejun Li, Zhongyu Wang, Haifeng Luo · 2012 · PLoS ONE
21. MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
    N.V. Rajeshkumar, Elizabeth De Oliveira, Niki A. Ottenhof, James Watters, David G. Brooks, Tim Demuth, Stuart D. Shumway, Shinji Mizuarai, Hiroshi Hirai, Anirban Maitra et al. · 2011 · Clinical Cancer Research
22. Early Detection of Recurrent Breast Cancer Using Metabolite Profiling
    Vincent M. Asiago, Leiddy Z. Alvarado, Narasimhamurthy Shanaiah, G. A. Nagana Gowda, Kwadwo Owusu-Sarfo, Robert A. Ballas, Daniel Raftery · 2010 · Cancer Research
23. Pancreatic Cancers Epigenetically Silence SIP1 and Hypomethylate and Overexpress miR-200a/200b in Association with Elevated Circulating miR-200a and miR-200b Levels
    Ang Li, Noriyuki Omura, Seung‐Mo Hong, Audrey Vincent, Kimberly Walter, Margaret Griffith, Michael W. Borges, Michael Goggins · 2010 · Cancer Research
24. Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
    Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Elena Fountzilas, Nancy J. Francoeur, Srisowmya Sanisetty, Alexandros P. Grammatikos, Jonathan L. Hecht, Stephen A. Cannistra · 2011 · Cancer Research
25. Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension
    Juan Ignacio Martínez‐Salamanca, William C. W. Huang, Isabel Millán, Roberto Bertini, Fernando J. Bianco, Joaquı́n Carballido, Gaetano Ciancio, Carlos E. Hernandez, Felipe Vilas Herranz, Axel Haferkamp et al. · 2010 · European Urology
26. Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment
    Mark S. Soloway, Cynthia T. Soloway, Ahmed Eldefrawy, Kristell Acosta, Bruce Kava, Murugesan Manoharan · 2010 · European Urology
27. Survival differences among women with de novo stage IV and relapsed breast cancer
    Shaheenah S. Dawood, Kristine R. Broglio, Joe Ensor, Gabriel N. Hortobágyi, Sharon Hermes Giordano · 2010 · Annals of Oncology
28. Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung Cancer
    Giorgio V. Scagliotti, Ugo Pastorino, Johan Vansteenkiste, Lorenzo Spaggiari, Francesco Facciolo, Tadeusz Maria Orlowski, Luigi Maiorino, M Hetzel, Monika Iris Leschinger, Carla Visseren‐Grul et al. · 2011 · Journal of Clinical Oncology
29. Bioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry
    Dilani D. De Silva, Sylvie Rapior, Enge Sudarman, Marc Stadler, Jianchu Xu, Siti Aisyah Alias, Kevin D. Hyde · 2013 · Fungal Diversity
30. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
    Tomohiro Fujiwara, Mohamed A. Yakoub, Andrew Chandler, Alexander B. Christ, Guangli Yang, Ouathek Ouerfelli, Vinagolu K. Rajasekhar, Aki Yoshida, Hiroya Kondo, Toshiaki Hata et al. · 2021 · Molecular Cancer Therapeutics
31. Screening for Colorectal Cancer
    David A. Lieberman · 2009 · New England Journal of Medicine
32. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry
    John D. Cramer, Pingfu Fu, Karem Clementina Harth, Seunghee Park Margevicius, Scott M. Wilhelm · 2010 · Surgery
33. Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies
    Hatem A. Azim, Luigi Santoro, Nicholas A. Pavlidis, Shari I. Gelber, Niels T. Kroman, Hamdy A. Azim, Fedro Alessandro Peccatori · 2010 · European Journal of Cancer
34. Long-Term Complications of Conduit Urinary Diversion
    Mark S. Shimko, Matthew K. Tollefson, Eric C. Umbreit, Sara A. Farmer, Michael L. Blute, Igor Frank · 2010 · The Journal of Urology
35. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
    Yilei Mao, Huayu Yang, Haifeng C. Xu, Xin Lu, Xinting Sang, Shunda Du, Haitao Zhao, Wang Chen, Yiyao Xu, Tianyi Chi et al. · 2010 · Gut
36. Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study
    Sam Joseph Lubner, Michelle R. Mahoney, Jill Kolesar, Noelle K. LoConte, George P. Kim, Henry Clement Pitot, Philip A. Philip, Joel Picus, Wei Peng Yong, Lisa Glen Horvath et al. · 2010 · Journal of Clinical Oncology
37. SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
    Christoph Kneip, Bernd Schmidt, Anke Seegebarth, Sabine Weickmann, Michael Fleischhacker, Volker Liebenberg, John K. Field, Dimo Dietrich · 2011 · Journal of Thoracic Oncology
38. Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
    Chad A. Hall, Runsheng Wang, Jiangyong Miao, Esther Oliva, Xiaoyun Shen, Thomas M. Wheeler, Susan Galloway Hilsenbeck, Sandra Oršulić, Scott Goode · 2010 · Cancer Research
39. Appendiceal Mucinous Neoplasms: Diagnosis and Management
    Walid Labib Shaib, Rita Elias Assi, Ali I. Shamseddine, Olatunji Boladale Alese, Charles A. Staley, Bahar Memiş, Volkan N. Adsay, Tanios Bekaii‐Saab, Bassel F. El‐Rayes · 2017 · The Oncologist
40. Screening for lung cancer
    Renee L. Manser, Anne E. Lethaby, Louis B. Irving, Christine Stone, Graham B Byrnes, Michael John Abramson, Donald A. Campbell · 2013 · Cochrane Database of Systematic Reviews
41. Trends in Colorectal Cancer Incidence by Anatomic Site and Disease Stage in the United States From 1976 to 2005
    Lee Cheng, Cathy Eng, Linda Z. Nieman, Asha Seth Kapadia, Xianglin L. Du · 2011 · American Journal of Clinical Oncology
42. Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial
    Takashi Ishida, Fumihiro Asano, K Yamazaki, Naofumi Shinagawa, Satoshi Oizumi, H. Moriya, M. Munakata, Masaharu Nishimura, for the Virtual Navigation in Japan (V-NINJA) trial group · 2011 · Thorax
43. Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
    Mami Murakami, Horacio Cabral, Yu Matsumoto, Shourong Wu, Mitsunobu R. Kano, Takao Yamori, Nobuhiro Nishiyama, Kazunori Kataoka · 2011 · Science Translational Medicine
44. Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic Status
    Robert E. Bristow, Matthew A. Powell, Noor J. Al-Hammadi, Lan Chen, J. Philip Miller, P. Roland, David Gardner Mutch, William A. Cliby · 2013 · JNCI Journal of the National Cancer Institute
45. Novel diagnostic biomarkers for prostate cancer
    Chikezie O. Madu, Yi Lu · 2010 · Journal of Cancer
46. CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
    Martin Turcotte, Kathleen Spring, Sandra Pommey, Guillaume Chouinard, Isabelle Cousineau, Joshy George, Gregory M. Chen, Deena M.A. Gendoo, Benjamin Haibe‐Kains, Thomas Karn et al. · 2015 · Cancer Research
47. Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
    Adcock, Ian M., Caramori, Gaetano, Barnes, Peter J. · 2011 · Respiration
48. Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma
    Jamie Christopher Messer, Shahrokh François Shariat, James C. Brien, Michael P. Herman, Casey K. Ng, Douglas S. Scherr, Benjamin J. Scoll, Robert G. Uzzo, Mark A. Wille, Scott E. Eggener et al. · 2011 · British Journal of Urology
49. A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
    Samuel C. Mok, Tomás Bonome, Vinod Vathipadiekal, Aaron Bell, Michael E. Johnson, Kwong‐Kwok Wong, Dong-Choon Park, Ke Hao, Daniel K.P. Yip, Howard Donninger et al. · 2009 · Cancer Cell
50. PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
    Konstantin Johannes Dedes, Daniel Wetterskog, Ana M. Mendes‐Pereira, Rachael Natrajan, Maryou B. K. Lambros, Felipe Correa Geyer, Radost Vatcheva, Kay Savage, Alan G. Mackay, Christopher J. Lord et al. · 2010 · Science Translational Medicine
51. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age
    Gwen A Murphy, Susan S. Devesa, Amanda Jane Cross, Peter D. Inskip, Katherine A. McGlynn, Michael B. Cook · 2010 · International Journal of Cancer
52. Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
    Charles Chia-chuen Hsu, Joseph M. Herman, Michele M. Corsini, Jordan Michael Winter, Matthew D. Callister, Michael G. Haddock, John L. Cameron, Timothy Michael Pawlik, Richard David Schulick, Christopher Lee Wolfgang et al. · 2010 · Annals of Surgical Oncology
53. Clinical trials of antioxidants as cancer prevention agents: Past, present, and future
    Michael G Goodman, Roberd M. Bostick, Ömer Küçük, Dean P. Jones · 2011 · Free Radical Biology and Medicine
54. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Hiroyuki Tao, Y. Mimura, K. Aoe, Seiki Kobayashi, H. Yamamoto, Eisuke Matsuda, K. Okabe, Tsuneo Matsumoto, K. Sugi, H. Ueoka · 2012 · Lung Cancer
55. A Review of Triple-Negative Breast Cancer
    Roohi R. Ismail-Khan, Marilyn M. Bui · 2010 · Cancer Control
56. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
    Gagan Deep, Rajesh Agarwal · 2010 · Cancer and Metastasis Reviews
57. Prevalence and causes of burnout amongst oncology residents: A comprehensive nationwide cross-sectional study
    Pierre Blanchard, Didier Truchot, Laurence K. Albiges, Sylvain Dewas, Y. Pointreau, Manuel Jorge Rodrigues, Aliénor Xhaard, Yohann Loriot, Philippe Giraud, Jean‐Charles Soria et al. · 2010 · European Journal of Cancer
58. Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study
    Melissa Maria Hudson, Kirsten K. Ness, Vikki G. Nolan, Gregory T. Armstrong, Daniel M. Green, E. Brannon Morris, Sheri L. Spunt, Monika L. Metzger, Kevin R. Krull, James L. Klosky et al. · 2010 · Pediatric Blood & Cancer
59. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
    Michael A. Davies, Katherine Stemke‐Hale, E. Lin, Carmen S. Tellez, Wanleng Deng, Y.N. Vashisht Gopal, Scott Eric Woodman, Tiffany L. Calderone, Zhenlin Ju, Alexander J. Lazar et al. · 2009 · Clinical Cancer Research
60. LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
    Holly E. Barker, Joan Chang, Thomas R. Cox, Georgina Lang, Demelza Bird, Monica M Nicolau, Holly Evans, Alison Gartland, Janine Terra Erler · 2011 · Cancer Research
61. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review
    Kim D. G. van de Kant, Linda J. T. M. van der Sande, Quirijn Jöbsis, Onno C. P. van Schayck, Edward Dompeling · 2012 · Respiratory Research
62. Pancreatic Cancer Risk and ABO Blood Group Alleles: Results from the Pancreatic Cancer Cohort Consortium
    Brian Matthew Wolpin, Peter Kraft, Myron D. Gross, Kathy J. Helzlsouer, H. Bas Bueno-de-Mesquita, Emily Steplowski, Rachael Z. Stolzenberg‐Solomon, Alan A. Arslan, Eric J. Jacobs, Andrea Z. LaCroix et al. · 2010 · Cancer Research
63. CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling
    Kwan Ho Tang, Stephanie Ma, Terence K. Lee, Yuen Piu Chan, Pak Shing Kwan, Carol M. Tong, Irene Oi‐Lin Ng, Kwan Man, Ka‐Fai To, Paul B.S. Lai et al. · 2011 · Hepatology
64. Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma
    James C. Brien, Shahrokh François Shariat, Michael P. Herman, Casey K. Ng, Douglas S. Scherr, Benjamin J. Scoll, Robert G. Uzzo, Mark A. Wille, Scott E. Eggener, John D. Terrell et al. · 2010 · The Journal of Urology
65. Lifestyle as risk factor for cancer: Evidence from human studies
    Naghma Khan, Farrukh Afaq, Hasan Mukhtar · 2010 · Cancer Letters
66. Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
    Michael G. Schrauder, Reiner Strick, Rüdiger Schulz‐Wendtland, Pamela L. Strissel, Laura Kahmann, Christian R. Loehberg, Michael Patrick Lux, Sebastian Michael Jud, Arndt Hartmann, Alexander Hein et al. · 2012 · PLoS ONE
67. A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
    Marina Antelo, Francesc Balaguer, Jinru Shia, Yan Shen, Keun Hur, Leticia Moreira, Míriam Cuatrecasas, Luís Bujanda, Maria Dolores Giraldez, Masanobu Takahashi et al. · 2012 · PLoS ONE
68. MicroRNA in lung cancer
    P-Y Lin, Sung‐Liang Yu, P-C Yang · 2010 · British Journal of Cancer
69. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
    Xingxing Zang, Peggy S Sullivan, Robert A. Soslow, Rebecca Waitz, Victor E. Reuter, Andrew S. Wilton, Howard T. Thaler, Manonmani Arul, Susan F. Slovin, Joyce Wei et al. · 2010 · Modern Pathology
70. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
    Xiaoguang Liu, Wangyu Zhu, Yanyan Huang, Lina Ma, Shiquan Zhou, Yekai Wang, Zeng Fang, Jihang Zhou, Yongkui Zhang · 2011 · Medical Oncology
71. Rational Therapeutic Combinations with Histone Deacetylase Inhibitors for the Treatment of Cancer
    Kenneth T. Thurn, Scott Thomas, Amy Patricia Moore, Pamela N. Münster · 2011 · Future Oncology
72. Effect of Preoperative Nutritional Deficiency on Mortality After Radical Cystectomy for Bladder Cancer
    Justin R. Gregg, Michael S. Cookson, Sharon E. Phillips, Shady Mohamed Salem, Sam S. Chang, Peter E. Clark, Rodney Davis, C.J. Stimson, Monty A. Aghazadeh, Joseph A. Jr Smith et al. · 2010 · The Journal of Urology
73. Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
    Sara M. Johnson, Pat Gulhati, Bill A. Rampy, Yimei Han, Piotr G. Rychahou, Hung Q. Doan, Heidi L. Weiss, Bernard Mark Evers · 2010 · Journal of the American College of Surgeons
74. Review of MR elastography applications and recent developments
    Kevin J. Glaser, Armando Manduca, Richard L. Ehman · 2012 · Journal of Magnetic Resonance Imaging
75. Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
    Birgit Gruenberger, Johann Schueller, Ute Heubrandtner, Fritz Wrba, Dietmar Tamandl, Klaus Kaczirek, Rudolf Roka, Sandra Freimann-Pircher, Thomas Gruenberger · 2010 · The Lancet Oncology
76. Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
    Kornelius Schulze, Christin Gasch, Katharina Staufer, Björn Nashan, Ansgar Wilhelm Lohse, Klaus Pantel, Sabine Riethdorf, Henning Wege · 2013 · International Journal of Cancer
77. An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
    Maeve Aine Lowery, David Paul Kelsen, Zsofia Kinga Stadler, Kenneth H. Yu, Yelena Yuriy Janjigian, Emmy Ludwig, David R. D’Adamo, Erin E. Salo‐Mullen, Mark E. Robson, Peter J. Allen et al. · 2011 · The Oncologist
78. MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
    Dong Li, Xingguang Liu, Li Lin, Jin Hou, Nan Li, Chunmei Wang, Pin Wang, Qian Zhang, Peng Zhang, Weiping Zhou et al. · 2011 · Journal of Biological Chemistry
79. Sunbed use during adolescence and early adulthood is associated with increased risk of early‐onset melanoma
    Anne Elizabeth Cust, Bruce Konrad Armstrong, Chris Goumas, Mark A. Jenkins, Helen Schmid, John Llewelyn Hopper, Richard F. Kefford, Graham G. Giles, Joanne F. Aitken, Graham J. Mann · 2010 · International Journal of Cancer
80. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
    Adam Lister, Taoufik Nedjadi, Neil R. Kitteringham, Fiona Campbell, Eithne Costello, Bryony H. Lloyd, Ian M. Copple, Samantha J. Williams, Andrew Owen, John P. Neoptolemos et al. · 2011 · Molecular Cancer
81. Targeted cancer therapies
    Saurabh Aggarwal · 2010 · Nature Reviews Drug Discovery
82. Variation of Adenoma Prevalence by Age, Sex, Race, and Colon Location in a Large Population: Implications for Screening and Quality Programs
    Douglas A. Corley, Christopher D. Jensen, Amy R. Marks, Wei K. Zhao, Jolanda de Boer, Theodore R. Levin, Chyke A. Doubeni, BRUCE H. FIREMAN, Charles P. Quesenberry · 2012 · Clinical Gastroenterology and Hepatology
83. Barrett's Esophagus
    Prateek Sharma · 2009 · New England Journal of Medicine
84. Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
    Alexander B. Stillebroer, Peter Mulders, Otto C. Boerman, Wim J.G. Oyen, Egbert Oosterwijk · 2010 · European Urology
85. Overcoming drug resistance in pancreatic cancer
    Jiang Long, Yuqing Zhang, Xianjun Yu, Jingxuan Yang, Drake G. LeBrun, Changyi Chen, Qizhi Cathy Yao, Min Li · 2011 · Expert Opinion on Therapeutic Targets
86. Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma
    Gerben Duns, Eva van den Berg, Inge van Duivenbode, Jan Osinga, Harry Hollema, Robert M.W. Hofstra, Klaas Kok · 2010 · Cancer Research
87. A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
    Bodoky, György, Timcheva, Constanta, Spigel, David Robert, La Stella, Phillip Joseph, Ciuleanu, Tudor Eliade, Pover, G., Tebbutt, N. C. · 2012 · Investigational New Drugs
88. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
    E L Wang, Zhi Rong Qian, Masahiko Nakasono, Toshihito Tanahashi, Katsuhiko Yoshimoto, Yoshiyuki Bando, Eiji Kudo, Mitsuo Shimada, Toshiaki Sano · 2010 · British Journal of Cancer
89. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
    Viren Asher, Joanne Lee, Anni Innamaa, Anish Bali · 2011 · Clinical & Translational Oncology
90. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus
    Neil Gupta, Srinivas Gaddam, Sachin B. Wani, Ajay Kr Bansal, Amit Nath Rastogi, Prateek Sharma · 2012 · Gastrointestinal Endoscopy
91. PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
    Robert Wendel Naumann, Robert Louis Coleman, Robert Allen Burger, Edward A. Sausville, Elzbieta Kutarska, Sharad A. Ghamande, Nashat Y. Gabrail, Stephen E. DePasquale, Elżbieta Nowara, Lucy Gilbert et al. · 2013 · Journal of Clinical Oncology
92. Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
    Gianluca Masi, Fotios Loupakis, Lisa Salvatore, Lorenzo Fornaro, Chiara Cremolini, Samanta Cupini, Andrea Ciarlo, Francesca Del Monte, Enrico Cortesi, DOMENICO AMOROSO et al. · 2010 · The Lancet Oncology
93. Gold Nanocages: A Novel Class of Multifunctional Nanomaterials for Theranostic Applications
    Jingyi Chen, Miaoxin Yang, Qiang Zhang, Eun Chul Cho, Claire M. Cobley, Chulhong Kim, Charles Glaus, Lihong V. Wang, Michael John Welch, Younan Xia A · 2010 · Advanced Functional Materials
94. Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Kim N. Chi, Sebastién J. Hotte, Evan Y. Yu, Dongsheng Tu, Bernhard J. Eigl, Ian F. Tannock, Fred Saad C, Scott A. North, Jean Powers, Martin Edwin Gleave et al. · 2010 · Journal of Clinical Oncology
95. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
    Vanessa Deschoolmeester, Marc F.D. Baay, Eric Van Marck, Joost Weyler, Peter B. Vermeulen, Filip Lardon, Jan Baptist Vermorken · 2010 · BMC Immunology
96. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer
    Imtiaz Ahmad Siddiqui, Mohammad Asim, Bilal Bin Hafeez, Vaqar Mustafa Adhami, Rohinton S. Tarapore, Hasan Mukhtar · 2010 · The FASEB Journal
97. First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
    Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo, Ronald D. Feld, Charles Andrew Butts, Vittorio Gebbia, Paolo Maione, Floriana Morgillo, Giovenzio Genestreti, Adolfo Gino Favaretto et al. · 2012 · Journal of Clinical Oncology
98. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms
    Alberto Múñoz, William Burgess Grant · 2022 · Nutrients
99. An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
    Qing Sheng, Xinggang Liu, ELEANOR M. FLEMING, Karen Yuan, Huiying Piao, Jinyun Chen, ZEINAB R. MOUSTAFA, Roman Kurt Thomas, Heidi E. Greulich, Anna C. Schinzel et al. · 2010 · Cancer Cell
100. Sexual function after breast cancer
     Panjari, Mary, Bell, Robin J., Davis, Susan R. · 2011 · The Journal of Sexual Medicine